Shares purchased by BioGaia´s Chairman Mauricio Graber

Mauricio Graber, newly elected chairman of the board has entered into an agreement to purchase 735,754 class B shares from Anatom Holding, BioGaia’s anchor shareholder.

The significant investment underlines Mauricio Graber’s commitment to actively supporting the company’s future development and its management team and creates a strong alignment of interests with all stakeholders.

Following settlement of the transaction, Anatom will hold 1,776,758 A shares and 4,845,021 B shares (6.5% of the total number of shares and 18.1% of the total number of votes).

About Mauricio Graber
Mauricio Graber, has extensive and solid experience as a CEO in the food ingredients sector, as well as leadership roles within the nutrition and health sectors. He served as President and CEO of Chr. Hansen A/S from 2018 to 2024, and as President of the Flavour Division at Givaudan AG from 2006 to 2018, having previously held other leading positions within Givaudan. Mauricio Graber is a member of the Board of Directors and Deputy Chairman of the Board of Directors of Jungbunzlauer Holding AG, holds Board assignments in Barry Callebaut AG and AM SILK GmbH, and is a member of the Advisory Board of Novo Holdings A/S.
 

Follow us:
Subscribe to BioGaia press releases here
LinkedIn here

Contacts:
Alexander Kotsinas, CFO
Email: [email protected]
Phone: +46 735 00 11 11

About BioGaia
BioGaia is a Swedish probiotic company that has been at the forefront of microbiome research for more than 35 years. BioGaia develops, markets, and sells probiotic products focused on gut health, immune health, and oral health. The products are sold through local distribution partners or via own distribution in over 100 markets. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. biogaiagroup.com